Abstract.
We compared the effects of Alzheimer's peptide (Aβ 1–42), α 1-antichymotrypsin (ACT) and an ACT/Aβ 1–42 mixture on human glioma DK-MG cells. The solution of Aβ (5 μM) formed by 2-h incubation at room temperature induced tumour necrosis factor-α (TNF-α) and interleukin (IL)-6 levels by 55 and 45%, respectively, and increased gelatinase B activity by 67%, while exposure of cells to the ACT/Aβ 1–42 mixture (1:10 molar ratio ACT: Aβ 1–42) under the same experimental conditions showed no effect on IL-6 levels or gelatinase B activity, but strongly induced TNF-α (by 190%), compared to the controls. Stimulation of the cells with Aβ 1–42 alone, but not with ACT, increased by about 20% low-density lipoprotein (LDL) uptake and mRNA levels for LDL receptor and HMG-CoA reductase, while the ACT/Aβ 1–42 mixture significantly increased LDL uptake (by 50%), up-regulated mRNA levels for LDL receptor and HMG-CoA reductase by 48 and 63%, respectively, and increased lipid accumulation by about 20-fold. These data suggest a possible new role for Aβ in Alzheimer's disease through its interaction with the inflammatory reactant, ACT.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 23 May 2002; received after revision 6 August 2002; accepted 13 August 2002
RID="*"
ID="*"Corresponding author.
Rights and permissions
About this article
Cite this article
Sun, Y., Wright, H. & Janciauskiene, S. Glioma cell activation by Alzheimer's peptide Aβ 1–42, α 1-antichymotrypsin, and their mixture. CMLS, Cell. Mol. Life Sci. 59, 1734–1743 (2002). https://doi.org/10.1007/PL00012501
Issue Date:
DOI: https://doi.org/10.1007/PL00012501